Vitamin D and the Epithelial to Mesenchymal Transition

Overview

Journal Stem Cells Int

Publisher Wiley

Specialty Cell Biology

Date 2016 Feb 17

PMID 26880977

Citations 29

Authors

Maria Jesus Larriba

Antonio Garcia de Herreros

Alberto Munoz

Affiliations

Soon will be listed here.

Abstract

Several studies support reciprocal regulation between the active vitamin D derivative 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) and the epithelial to mesenchymal transition (EMT). Thus, 1,25(OH)2D3 inhibits EMT via the induction of a variety of target genes that encode cell adhesion and polarity proteins responsible for the epithelial phenotype and through the repression of key EMT inducers. Both direct and indirect regulatory mechanisms mediate these effects. Conversely, certain master EMT inducers inhibit 1,25(OH)2D3 action by repressing the transcription of VDR gene encoding the high affinity vitamin D receptor that mediates 1,25(OH)2D3 effects. Consequently, the balance between the strength of 1,25(OH)2D3 signaling and the induction of EMT defines the cellular phenotype in each context. Here we review the current understanding of the genes and mechanisms involved in the interplay between 1,25(OH)2D3 and EMT.

Citing Articles

Unveiling the Link: The Potential Roles of Vitamin D in Keloid Pathophysiology.

Kotze J, Nortje E, Phulukdaree A, Fear M, Wood F, Bester J Exp Dermatol. 2025; 34(2):e70043.

PMID: 39895409 PMC: 11788883. DOI: 10.1111/exd.70043.

is overexpressed in keloid keratinocytes and its inhibition alters profibrotic gene expression.

Hahn J, Combs K, Phillips C, Warner P, Qazi U, Powell H Burns Trauma. 2025; 13():tkae063.

PMID: 39822648 PMC: 11736898. DOI: 10.1093/burnst/tkae063.

Vitamin D in Cancer Prevention and Treatment: A Review of Epidemiological, Preclinical, and Cellular Studies.

Dallavalasa S, Tulimilli S, Bettada V, Karnik M, Uthaiah C, Anantharaju P Cancers (Basel). 2024; 16(18).

PMID: 39335182 PMC: 11430526. DOI: 10.3390/cancers16183211.

Associations between diet and nutritional supplements and colorectal cancer: A systematic review.

Gholamalizadeh M, Tajadod S, Majidi N, Aghakhaninejad Z, Mahmoudi Z, Mousavi Z JGH Open. 2024; 8(7):e13108.

PMID: 39027159 PMC: 11256152. DOI: 10.1002/jgh3.13108.

Metabolic alterations and mitochondrial dysfunction in human airway BEAS-2B cells exposed to vanadium pentoxide.

He X, Smith M, Jarrell Z, Thi Ly V, Liang Y, Lee C Toxicology. 2024; 504:153772.

PMID: 38479551 PMC: 11060939. DOI: 10.1016/j.tox.2024.153772.

References

De Craene B, Berx G . Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013; 13(2):97-110. DOI: 10.1038/nrc3447. View

Carlberg C, Seuter S . A genomic perspective on vitamin D signaling. Anticancer Res. 2009; 29(9):3485-93. View

Nieto M . The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol. 2011; 27:347-76. DOI: 10.1146/annurev-cellbio-092910-154036. View

Pereira F, Barbachano A, Silva J, Bonilla F, Campbell M, Munoz A . KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. Hum Mol Genet. 2011; 20(23):4655-65. DOI: 10.1093/hmg/ddr399. View

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

Palmer H, Sanchez-Carbayo M, Ordonez-Moran P, Larriba M, Cordon-Cardo C, Munoz A . Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res. 2003; 63(22):7799-806. View

Knackstedt R, Moseley V, Sun S, Wargovich M . Vitamin D receptor and retinoid X receptor α status and vitamin D insufficiency in models of murine colitis. Cancer Prev Res (Phila). 2013; 6(6):585-93. PMC: 3674145. DOI: 10.1158/1940-6207.CAPR-12-0488. View

Palmer H, Gonzalez-Sancho J, Espada J, Berciano M, Puig I, Baulida J . Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol. 2001; 154(2):369-87. PMC: 2150773. DOI: 10.1083/jcb.200102028. View

Campbell F, Xu H, El-Tanani M, Crowe P, Bingham V . The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control. Biochem Pharmacol. 2009; 79(1):1-9. PMC: 2824849. DOI: 10.1016/j.bcp.2009.09.005. View

10.

Tan X, He W, Liu Y . Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy. Kidney Int. 2009; 76(12):1248-57. PMC: 5527548. DOI: 10.1038/ki.2009.346. View

11.

Puisieux A, Brabletz T, Caramel J . Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol. 2014; 16(6):488-94. DOI: 10.1038/ncb2976. View

12.

Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T . A nonclassical vitamin D receptor pathway suppresses renal fibrosis. J Clin Invest. 2013; 123(11):4579-94. PMC: 3809783. DOI: 10.1172/JCI67804. View

13.

Campbell M, Elstner E, Holden S, Uskokovic M, Koeffler H . Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. J Mol Endocrinol. 1997; 19(1):15-27. DOI: 10.1677/jme.0.0190015. View

14.

Fujita H, Sugimoto K, Inatomi S, Maeda T, Osanai M, Uchiyama Y . Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes. Mol Biol Cell. 2008; 19(5):1912-21. PMC: 2366872. DOI: 10.1091/mbc.e07-09-0973. View

15.

Ben-Batalla I, Seoane S, Garcia-Caballero T, Gallego R, Macia M, Gonzalez L . Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasis. J Clin Invest. 2010; 120(12):4289-302. PMC: 2993584. DOI: 10.1172/JCI42015. View

16.

Pendas-Franco N, Gonzalez-Sancho J, Suarez Y, Aguilera O, Steinmeyer A, Gamallo C . Vitamin D regulates the phenotype of human breast cancer cells. Differentiation. 2007; 75(3):193-207. DOI: 10.1111/j.1432-0436.2006.00131.x. View

17.

Zheng W, Wong K, Zhang Z, Dougherty U, Mustafi R, Kong J . Inactivation of the vitamin D receptor in APC(min/+) mice reveals a critical role for the vitamin D receptor in intestinal tumor growth. Int J Cancer. 2011; 130(1):10-9. PMC: 3770157. DOI: 10.1002/ijc.25992. View

18.

Kim C, Joo S, Lee K, Choi J, Bae E, Ma S . Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. PLoS One. 2013; 8(5):e63186. PMC: 3656901. DOI: 10.1371/journal.pone.0063186. View

19.

Xu H, Posner G, Stevenson M, Campbell F . Apc(MIN) modulation of vitamin D secosteroid growth control. Carcinogenesis. 2010; 31(8):1434-41. PMC: 2915628. DOI: 10.1093/carcin/bgq098. View

20.

Ramirez A, Wongtrakool C, Welch T, Steinmeyer A, Zugel U, Roman J . Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol. 2009; 118(3):142-50. PMC: 2821704. DOI: 10.1016/j.jsbmb.2009.11.004. View